| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 11 |
| 1 | ASPIRIN 325 MG | 11 |
| 2 | ASPIRIN 81 MG | 11 |
| 3 | FUROSEMIDE | 11 |
| 4 | CITALOPRAM | 10 |
| 5 | MIRTAZAPINE | 10 |
| 6 | PREDNISOLONE | 9 |
| 7 | PREDNISOLONE ORAL | 9 |
| 8 | PREDNISOLONE ORAL SOLUTION | 9 |
| 9 | AMLODIPINE BESYLATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UNDECYLENIC ACID | 1 | 0.0072 |
| 1 | MINERAL OIL, WHITE PETROLATUM | 2 | 0.0069 |
| 2 | TOLNAFTATE 1% | 1 | 0.0034 |
| 3 | CALCIUM ANTACID | 1 | 0.0023 |
| 4 | CARBIDOPA TABLETS | 6 | 0.0020 |
| 5 | POTASSIUM ACETATE | 2 | 0.0014 |
| 6 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 7 | CARBIDOPA LEVODOPA | 3 | 0.0008 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 3 | 0.0008 |
| 9 | SILODOSIN | 3 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 25 |
| 1 | Loop Diuretic [EPC] | 17 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 13 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 5 | Benzodiazepine [EPC] | 9 |
| 6 | Factor Xa Inhibitor [EPC] | 9 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 8 | Insulin Analog [EPC] | 9 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 6 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 7 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 8 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 9 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |